Post Market Clinical Follow Up (PMCF) Medical Device Registry of Z-Systems Zirconia Dental Products: Z-Systems Registry
1 other identifier
observational
240
2 countries
5
Brief Summary
Commercially pure (CP) titanium is the gold standard to produce dental implants because it has a huge volume of scientific publications over a period of more than 50 years, it is cheap and simple to produce (i.e., making dental implants economically "affordable") and comes in numerous specific designs of screws for various indications. That is why more than 95% of the implant market is dominated by titanium. However, there is an innovation trend to manufacture implants from more inert and biocompatible materials. Ceramic implants represent a valuable alternative for expanding the patient base of clinicians, especially in cases with challenging aesthetic demand. Furthermore, there has been a significant increase in the number of patients requesting metal-free dentistry or bio-holistic implant treatments. In the past, ceramics were often branded as "inferior" quality due to its reputation as being brittle but the growing volume of scientific publications specifically on zirconia are demonstrating that it is comparable in fracture-strength with titanium implants. There is a clear market niche for zirconia implants, especially in cases of:
- Aesthetic reconstructions in the anterior region, especially in patients with a thin gingival biotype
- Gingival recessions where a white colored implant is a great advantage
- For patients with a titanium intolerance/sensitivity
- For patients who prefer a bio-holistic/metal-free dental approach. Today, clinicians are asking for long-term clinical results of zirconia as a dental implant material. Therefore, Z-Systems AG is conducting this zirconia dental implant registry. A registry design was chosen because it will capture long-term benefits/risks from clinical routine without patient selection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2022
Longer than P75 for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 16, 2022
CompletedFirst Posted
Study publicly available on registry
June 22, 2022
CompletedStudy Start
First participant enrolled
July 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2028
ExpectedJanuary 28, 2025
May 1, 2024
3.3 years
June 16, 2022
January 23, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Absence of persistent subjective complaints
Absence of persistent subjective complaints such as pain, foreign body sensation and/or dysesthesia
12 months post-loading final prostheis
Absence of peri-implant infection
Absence of peri-implant infection with suppuration
12 months post-loading final prostheis
Absence of mobility
Absence of mobility of dental implant
12 months post-loading final prostheis
Secondary Outcomes (4)
Frequency of occurrence of device related Adverse Device Events (ADEs) and Serious Adverse Device Events (SADEs).
At implant surgery, 3 months, 6 months, 1-5 years post-loading with the final prosthesis (i.e., at every follow-up visit after implant surgery)
Exploratory outcomes - complaints and incidence
At implant surgery, 3 months, 6 months, 1-5 years post-loading with the final prosthesis (i.e., at every follow-up visit after implant surgery)
Exploratory outcomes - clinical satisfaction
At implant surgery, 3 months, 6 months, 1-5 years post-loading with the final prosthesis (i.e., at every follow-up visit after implant surgery)
Exploratory outcomes - patient satisfaction
At implant surgery, 3 months, 6 months, 1-5 years post-loading with the final prosthesis (i.e., at every follow-up visit after implant surgery)
Study Arms (2)
Z5-BL Dental Implants
Z5-TL Dental Implants
Interventions
This is an observational study, collecting data on the use of Z5-BL Dental Implants.
This is an observational study, collecting data on the use of Z5-BL Dental Implants.
Eligibility Criteria
The patient population are anyone needing to have their missing teeth replaced.
You may qualify if:
- Adult patient (≥ 18 years) was or will be implanted with up to 5 implants of the Z-Systems Z5-BL or Z5-TLproduct group
- Patient has signed Informed Consent.
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Z-Systemslead
Study Sites (5)
MVZ Stiller GmbH
Berlin, 14193, Germany
Gemeinschaftspraxis Börner, Hagen
Köpenick, 12559, Germany
Praxis dentblanche AG
Solothurn, Grenchen, 2540, Switzerland
Praxis am Klosterplatz
Olten, 4600, Switzerland
HeilPraxis - ZahnMedizin
Sankt Gallen, 9000, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mariane Sordi
Z-Systems
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 5 Years
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 16, 2022
First Posted
June 22, 2022
Study Start
July 1, 2022
Primary Completion
November 1, 2025
Study Completion (Estimated)
September 1, 2028
Last Updated
January 28, 2025
Record last verified: 2024-05